Mary Carrington Selected Research

Mary Carrington Research Topics

Disease

67	Infections 04/2024 - 05/2002
23	Acquired Immunodeficiency Syndrome (AIDS) 01/2024 - 01/2002
23	Viremia 12/2023 - 09/2006
21	Neoplasms (Cancer) 01/2024 - 04/2002
20	Disease Progression 01/2019 - 10/2006
18	HIV Infections (HIV Infection) 05/2024 - 05/2006
9	Virus Diseases (Viral Diseases) 01/2017 - 08/2002
6	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2020 - 06/2007
5	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2024 - 11/2007
4	COVID-19 01/2022 - 01/2021
4	Communicable Diseases (Infectious Diseases) 12/2021 - 01/2003
3	Disease Susceptibility (Diathesis) 01/2023 - 04/2015
3	Nasopharyngeal Carcinoma 01/2012 - 11/2005
3	Myositis (Idiopathic Inflammatory Myopathies) 11/2006 - 11/2005
2	Head and Neck Neoplasms (Head and Neck Cancer) 01/2024 - 01/2021
2	Liver Diseases (Liver Disease) 10/2023 - 06/2011
2	Inflammation (Inflammations) 10/2023 - 10/2020
2	Urinary Bladder Neoplasms (Bladder Cancer) 12/2022 - 01/2022
2	Hepatitis C 01/2022 - 06/2009
2	Malaria 01/2022 - 12/2017
2	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2020 - 02/2012
2	Kaposi Sarcoma (Kaposi's Sarcoma) 11/2019 - 02/2016
2	Persistent Infection 01/2018 - 06/2012
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2018 - 06/2010
2	Hypersensitivity (Allergy) 01/2017 - 03/2011
2	Crohn Disease (Crohn's Disease) 12/2013 - 04/2013
2	Chronic Hepatitis B 06/2012 - 11/2003
2	Hepatitis B 06/2012 - 12/2008
2	Polymyositis 11/2006 - 11/2005
2	Dermatomyositis (Dermatopolymyositis) 11/2006 - 11/2005
2	Psoriatic Arthritis 10/2004 - 09/2002
1	Burkitt Lymphoma (Burkitt's Lymphoma) 01/2024
1	Sclerosing Cholangitis 10/2023
1	Pathologic Constriction (Stenosis) 10/2023
1	Ulcerative Colitis 10/2023
1	Glioma (Gliomas) 01/2023
1	Rhabdomyosarcoma 01/2023
1	Lung Neoplasms (Lung Cancer) 01/2023
1	Ewing Sarcoma (Sarcoma, Ewing) 01/2023
1	Osteosarcoma (Osteogenic Sarcoma) 01/2023

Drug/Important Bio-Agent (IBA)

29	HLA-B Antigens (HLA-B)IBA 05/2024 - 08/2002
28	HLA Antigens (Human Leukocyte Antigens)IBA 01/2024 - 04/2002
22	LigandsIBA 04/2024 - 05/2002
18	EpitopesIBA 01/2024 - 10/2006
18	Peptides (Polypeptides)IBA 11/2023 - 11/2005
16	HLA-C Antigens (HLA-C)IBA 01/2021 - 09/2002
14	Proteins (Proteins, Gene)FDA Link 02/2023 - 01/2003
12	RNA (Ribonucleic Acid)IBA 01/2024 - 06/2007
11	Antiviral Agents (Antivirals)IBA 04/2024 - 09/2002
11	VaccinesIBA 01/2022 - 05/2008
10	HLA-A Antigens (HLA-A)IBA 01/2024 - 10/2004
10	KIR ReceptorsIBA 01/2021 - 04/2005
7	DNA (Deoxyribonucleic Acid)IBA 01/2024 - 01/2014
7	AntigensIBA 01/2023 - 05/2006
6	Natural Killer Cell ReceptorsIBA 10/2023 - 08/2004
6	InterferonsIBA 01/2022 - 09/2006
6	Immunoglobulins (Immunoglobulin)IBA 02/2016 - 05/2002
4	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 11/2023 - 10/2006
4	tapasinIBA 11/2023 - 06/2014
4	HLA-DP Antigens (HLA-DP)IBA 10/2023 - 06/2012
4	Messenger RNA (mRNA)IBA 01/2022 - 07/2010
4	CytokinesIBA 01/2022 - 08/2002
4	HLA-B57 antigenIBA 01/2018 - 02/2011
3	Histocompatibility Antigens Class IIBA 01/2023 - 03/2007
3	Amino Acids FDA Link 01/2022 - 12/2010
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2004
3	HLA-DPB1 antigen (HLA DPB1)IBA 01/2020 - 06/2012
3	Interferon-gamma (Interferon, gamma)IBA 11/2014 - 06/2012
3	HLA-DRB1 Chains (HLA DRB1)IBA 07/2013 - 03/2006
3	ChemokinesIBA 11/2010 - 05/2009
3	Chemokine ReceptorsIBA 01/2007 - 01/2002
2	Histocompatibility Antigens Class IIIBA 01/2023 - 01/2008
2	transporter associated with antigen processing (TAP)IBA 01/2023 - 05/2003
2	HLA-DR Antigens (HLA-DR)IBA 01/2023 - 01/2002
2	Broadly Neutralizing AntibodiesIBA 12/2019 - 12/2015
2	Membrane Proteins (Integral Membrane Proteins)IBA 01/2017 - 06/2012
2	MicroRNAs (MicroRNA)IBA 12/2016 - 01/2014
2	EnzymesIBA 11/2014 - 11/2014
2	Codon (Codons)IBA 08/2014 - 08/2009
2	3' Untranslated Regions (3' UTR)IBA 12/2013 - 06/2012
2	HLA-DRB1*03:01 antigenIBA 07/2013 - 11/2006
2	HLA-Bw4 antigenIBA 06/2011 - 08/2007
2	Antigen Receptors (Antigen Receptor)IBA 05/2009 - 05/2009
2	DC-specific ICAM-3 grabbing nonintegrin (DC-SIGN)IBA 11/2007 - 12/2004
2	C-Type Lectins (C-Type Lectin)IBA 11/2007 - 12/2004
2	Isoleucine (L-Isoleucine)FDA Link 08/2007 - 08/2002
2	AutoantibodiesIBA 11/2006 - 03/2006
1	HLA-DPA1 antigen (HLA DPA1)IBA 10/2023
1	Retinoic Acid Receptors (Retinoic Acid Receptor)IBA 01/2023
1	Interleukin-13IBA 01/2023
1	Interleukin-5 (Interleukin 5)IBA 01/2023

Therapy/Procedure

15	Therapeutics 01/2024 - 10/2007
5	Transplantation 01/2022 - 12/2014
3	Immunotherapy 01/2024 - 12/2022
3	Art Therapy 12/2023 - 09/2014
3	Highly Active Antiretroviral Therapy (HAART) 03/2023 - 09/2006
3	Cell Transplantation 01/2020 - 01/2020
2	Precision Medicine 01/2023 - 12/2021
2	Aftercare (After-Treatment) 02/2022 - 01/2022
1	Liver Transplantation 10/2023